Stay updated on PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial
Sign up to get notified when there's something new on the PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial page.

Latest updates to the PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial page
- Check5 days agoChange DetectedStudy status updated to Completed with an actual completion date of 2025-09-22, and Last Update Posted and Revision metadata were added (Last Update Posted 2025-11-14; Revision: v3.3.2). A note in Publications indicates PubMed-sourced entries are auto-filled and may not all be about the study.SummaryDifference0.5%

- Check12 days agoChange DetectedRemoved a general funding-status notice that does not affect trial details, eligibility, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedExpanded and updated the list of trial sites on the Study Details page, listing numerous French locations. This provides current enrollment options and contact points for potential participants.SummaryDifference0.3%

- Check55 days agoChange Detected- Added a government funding lapse notice and operating-status guidance, and confirmed the NIH Clinical Center is open with sources. - Version updated from v3.1.0 to v3.2.0.SummaryDifference2%

- Check62 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0SummaryDifference0.0%

- Check77 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2 and the 'Back to Top' link was removed; no other substantive content changes.SummaryDifference0.1%

Stay in the know with updates to PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial page.